These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1725798)

  • 1. Regression of cardiovascular structural changes after long-term antihypertensive treatment with the calcium antagonist nitrendipine.
    Agabiti-Rosei E; Muiesan ML; Rizzoni D; Romanelli G; Beschi M; Castellano M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 5():S5-9. PubMed ID: 1725798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular structural changes and calcium antagonist therapy in patients with hypertension.
    Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Castellano M; Cavaliere G; Nordio G; Pasini F; Zuccato F
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S37-43. PubMed ID: 7603076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
    Ibrahim MM; el-Boghdadly B; Zaghloul SS
    J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive and humoral effects of verapamil and nifedipine in essential hypertension.
    Muiesan G; Agabiti-Rosei E; Castellano M; Alicandri CL; Corea L; Fariello R; Beschi M; Romanelli G
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S325-9. PubMed ID: 6184562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relations between antihypertensive and vascular effects of nitrendipine].
    Baylac-Domengetroy F; Baylac-Domengetroy J; Chaix AF; Elbaz-Rostykus C; Barraine R
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1295-9. PubMed ID: 2124470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regression of hypertrophy following nitrendipine: effect on systolic and diastolic function].
    Vogt M; Kreutz KU; Motz W; Strauer BE
    Z Kardiol; 1989 Jul; 78(7):469-77. PubMed ID: 2528245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.
    Nannan ME; Melin JA; Vanbutsele RJ; Lavenne F; Detry JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1043-8. PubMed ID: 6085364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of benazepril on ambulatory blood pressure, left ventricular mass, diastolic filling and aortic flow in essential hypertension.
    Porcellati C; Verdecchia P; Schillaci G; Boldrini F; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):187-97. PubMed ID: 1830037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiloride compared with nitrendipine in treatment of essential hypertension.
    Katzman PL; Henningsen NC; Hulthén UL
    J Hum Hypertens; 1988 Oct; 2(3):147-51. PubMed ID: 3236318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.
    Müller FB; Bolli P; Erne P; Block LH; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1073-6. PubMed ID: 6085370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral and hemodynamic effects of nitrendipine versus clonidine in patients with essential hypertension.
    Stornello M; Valvo EV; Scapellato L; Nazzari M
    Clin Ther; 1986; 8(5):510-9. PubMed ID: 3533265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term (3 years) sustained antihypertensive and metabolic actions of nitrendipine in severe, complicated, and resistant hypertension.
    Colina-Chourio JA; Godoy N; Oliveros-Palacios M; Arocha I
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S84-90. PubMed ID: 1723466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of vascular structural changes and calcium metabolism in patients with essential hypertension after long-term monotherapy with enalapril.
    Ueno H; Takata M; Oh-hashi S; Tomoda F; Yasumoto K; Iida H; Sasayama S
    J Hum Hypertens; 1993 Apr; 7(2):125-30. PubMed ID: 8510084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large arteries in hypertension: acute effects of a new calcium entry blocker, nitrendipine.
    Levenson J; Simon AC; Safar ME; Bouthier J; Maarek BC
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1006-10. PubMed ID: 6085357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saluretic and diuretic effects of antihypertensive nitrendipine monotherapy in man.
    Sambhi MP
    Angiology; 1988 Jan; 39(1 Pt 2):106-12. PubMed ID: 3341609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-aldosterone system, and blood pressure in essential hypertension.
    Cerasola G; Cottone S; Mangano MT; D'Ignoto G; Pinto A; Carone MB
    Clin Ther; 1988; 10(6):694-703. PubMed ID: 2975530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of acute and prolonged administration of nitrendipine in essential hypertension.
    Gregorini L; Perondi R; Grassi G; Saino A; Giannattasio C; Mancia G; Zanchetti A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S126-8. PubMed ID: 2455112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
    Weber MA; Drayer JI
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1077-84. PubMed ID: 6085371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrendipine and mefruside in elderly hypertensives: effects on blood pressure, cardiac output, cerebral blood flow and metabolic parameters.
    Landmark K; Forsman M; Lindberg K; Ryman T; Martmann-Moe K; Haaverstad S; Wiel S
    J Hum Hypertens; 1995 Apr; 9(4):281-5. PubMed ID: 7595911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.